of cell cycle control,
apoptosis and resistance to treatment, and the possible use of miRNAs in clinical
Beylerli, Ozal,
Beilerli, Aferin,
Shumadalova, Alina,
Wang, Xiaoxiong,
Yang, Mingchun,
Sun, Hanran,
Teng, Lei (2022) in glioblastoma models by modulating signaling pathways involved in angiogenesis,
apoptosis, chemoresistance
Usman, M.,
Beilerli, A.,
Sufianov, A.,
Kudryashov, V.,
Ilyasova, T.,
Balaev, P.,
Danilov, A.,
Lu, H.,
Gareev, I. (2023) apoptosis, activation of epidermal growth factor
receptor signaling pathway, etc. This article summarizes
FACHAL, L.,
KAR, S.,
TYRER, J.P.,
GHOUSSAINI, M.,
HARRINGTON, P.A.,
HEALEY, C.S.,
MAYES, R.,
SHAH, M.,
PHAROAH, P.D.P.,
EASTON, D.F.,
DUNNING, A.M.,
ASCHARD, H.,
JIANG, X.,
TAMIMI, R.M.,
KHUSNUTDINOVA, E.,
BIAŁKOWSKA, K.,
и др. соавторы (2020) . Known cancer drivers, transcription factors and genes in the developmental,
apoptosis, immune system
BEYLERLI, OZAL,
BEERAKA, NARASIMHA M.,
GAREEV, ILGIZ,
PAVLOV, VALENTIN,
YANG, GUANG,
LIANG, YANCHAO,
ALIEV, GJUMRAKCH (2020) proliferation, differentiation, and
apoptosis. Dysregulation of miRNAs has been observed in a number of diseases
Beylerli, O.A.,
Azizova, S.T.,
Konovalov, N.A.,
Akhmedov, A.D.,
Gareev, I.F.,
Belogurov, A.A. (2020) of spinal cord injury. These RNAs are associated with inflammation and
apoptosis, functional recovery